# | Title | Journal | Year | Citations |
---|
1 | Bone anabolic efficacy and safety of ba058, a novel analog of hPTHrP: 12-month extension data from a phase 2 clinical trial in postmenopausal women with osteoporosis | Bone Abstracts | 0 | 8 |
2 | Effect of blosozumab on bone mineral density: results of a phase 2 study of postmenopausal women with low bone mineral density | Bone Abstracts | 0 | 6 |
3 | Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms | Bone Abstracts | 0 | 6 |
4 | Mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion | Bone Abstracts | 0 | 5 |
5 | Meta-analysis of the effects of vitamin D supplements on bone mineral density in adults | Bone Abstracts | 0 | 4 |
6 | Sustained efficacy and tolerability in infants and young children with life-threatening hypophosphatasia treated with asfotase alfa | Bone Abstracts | 0 | 4 |
7 | Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results | Bone Abstracts | 0 | 4 |
8 | Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia | Bone Abstracts | 0 | 4 |
9 | Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone | Bone Abstracts | 0 | 3 |
10 | Protective effect of polyphenols from Aronia melanocarpa berries against cadmium-induced weakening of the femur biomechanical properties in rats | Bone Abstracts | 0 | 3 |
11 | Sarcopenia in patients scheduled to undergo orthopaedic surgery | Bone Abstracts | 0 | 3 |
12 | Constitutively elevated blood serotonin is associated with bone loss and type 2 diabetes in rats | Bone Abstracts | 0 | 3 |
13 | Development of osteoconductive and osteoinductive bone healing materials | Bone Abstracts | 0 | 3 |
14 | Financial burden in families of children with osteogenesis imperfecta (OI) | Bone Abstracts | 0 | 3 |
15 | Effective therapeutic control of curve progression using calcium and vitamin D supplementation for adolescent idiopathic scoliosis - a randomized double-blinded placebo-controlled trial | Bone Abstracts | 0 | 3 |
16 | Femur geometrical parameters in the pathogenesis of atypical femur fractures | Bone Abstracts | 0 | 2 |
17 | Anti-RANKL nanobody ALX-0141 shows sustained biomarker inhibition in a Phase I study in healthy postmenopausal Women | Bone Abstracts | 0 | 2 |
18 | Nucleotide and mechanically induced ATP release pathways in osteocytes | Bone Abstracts | 0 | 2 |
19 | Sclerostin/MEPE axis in OA: lessons from long bone development | Bone Abstracts | 0 | 2 |
20 | Prevalence of vitamin D deficiency and low bone mineral density in healthy Saudi women | Bone Abstracts | 0 | 2 |
21 | A case of atypical femoral fracture with abnormal cortical bone characterized by impaired mineralization and pyrophosphate accumulation | Bone Abstracts | 0 | 2 |
22 | Resolution of effects on bone turnover markers and bone mineral density after discontinuation of long-term bisphosphonate use | Bone Abstracts | 0 | 2 |
23 | Effect of polyphenolic compounds from Aronia melanocarpa berries on cadmium accumulation in the bone tissue | Bone Abstracts | 0 | 2 |
24 | Treatment with allopurinol and oxypurinol promotes osteoblast differentiation and increases bone formation | Bone Abstracts | 0 | 2 |
25 | Comparison of osteosarcoma incidence between abaloparatide (BA058) and PTH (1--34) in long term rat studies | Bone Abstracts | 0 | 2 |
26 | A transdermal patch delivering the PTHrP1-34 analog, abaloparatide (BA058), dose-dependently increases spine and hip bmd compared to placebo | Bone Abstracts | 0 | 2 |
27 | Increased expression of PTX3 in non-hematopoietic periosteal cells during fracture healing | Bone Abstracts | 0 | 2 |
28 | Improvement in bone manifestations and respiratory status in infants and young children with HPP treated with asfotase alfa: an update on the ENB-010-10 trial | Bone Abstracts | 0 | 2 |
29 | Burden of disease in children with hypophosphatasia: results from patient-reported surveys | Bone Abstracts | 0 | 2 |
30 | A longitudinal, prospective, long-term registry of patients with hypophosphatasia | Bone Abstracts | 0 | 2 |
31 | Dysosteosclerosis from a unique mutation in SLC29A3 | Bone Abstracts | 0 | 2 |
32 | Micro-RNA expression profiling in Paget's disease of bone | Bone Abstracts | 0 | 2 |
33 | A novel mutation of CYP27B1 in two siblings with vitamin D-dependent rickets type 1A | Bone Abstracts | 0 | 2 |
34 | Reference values of cortical thickness, bone width, and Bone Health Index in metacarpals of children from age 0 y, as determined with an extension of the fully automated BoneXpert bone age method | Bone Abstracts | 0 | 2 |
35 | A GWAS in an extreme high bone mass population shows excess signal from genes associated with BMD in the normal population | Bone Abstracts | 0 | 2 |
36 | An emerging role of phospho1 in the regulation of energy metabolism | Bone Abstracts | 0 | 2 |
37 | Virtual physiological human | Bone Abstracts | 0 | 2 |
38 | Ibandronate in the treatment of pediatric osteoporosis | Bone Abstracts | 0 | 2 |
39 | Impaired mobility and pain significantly impact the quality of life of children with X-linked hypophosphatemia | Bone Abstracts | 0 | 2 |
40 | High trabecular bone mass induced by reduced function of osteoclasts in GULP1-deficient mice | Bone Abstracts | 0 | 2 |
41 | Superior Gains in Bone Mineral Density (BMD) and Estimated Strength at the Hip for Romosozumab Compared With Teriparatide (TPTD) in Women With Postmenopausal Osteoporosis Transitioning From Bisphosphonate Therapy: Results of the Phase 3 Open-label STRUCTURE Study | Bone Abstracts | 0 | 2 |
42 | A novel form of congenital rickets due to a recurrent gain of function mutation in CYP3A4 | Bone Abstracts | 0 | 2 |
43 | KRN23 effects on phosphate and vitamin D dysregulation in children <5 years old with X-Linked Hypophosphatemia (XLH) | Bone Abstracts | 0 | 2 |
44 | Palovarotene inhibits the development of new heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) | Bone Abstracts | 0 | 2 |
45 | Severe osteopenia, increased bone marrow adipogenesis, and fibronectin matrix changes in mice lacking both TG2 and FXIIIA transglutaminases | Bone Abstracts | 0 | 1 |
46 | Cytotoxicity of picocyanobacteria strains of the genera Cyanobium on osteosarcoma cells | Bone Abstracts | 0 | 1 |
47 | Monosodium urate crystals inhibit tenocyte viability and function: implications for periarticular involvement in chronic gout | Bone Abstracts | 0 | 1 |
48 | Anti-dementia acetylcholine esterase inhibitor inhibits osteoclastogenesis | Bone Abstracts | 0 | 1 |
49 | Modulation of c-Myb during chondrogenesis | Bone Abstracts | 0 | 1 |
50 | The effect of different exercise modes on bone density in middle-aged and older men: a systematic review | Bone Abstracts | 0 | 1 |